The invention concerns anti-NGF antibodies (such as anti-NGF antagonist antibodies), and polynucleotides encoding the same. The invention further concerns use of such antibodies and/or polynucleotides in the treatment and/or prevention of pain, including post-surgical pain, rheumatoid arthritis pain, and osteoarthritis pain.

 
Web www.patentalert.com

< Diaminofluorescein derivatives

> Nanoparticles for monoclonal antibody delivery

> Method of identifying antinociceptive compounds using protease activated receptor-2

~ 00577